1 |
Sajja LR. Strategies to reduce deep sternal wound infection after bilateral internal mammary artery grafting[J]. Int J Surg, 2015, 16(Pt B): 171-178.
|
2 |
Dohmen PM, Misfeld M, Borger MA, et al. Closed incision management with negative pressure wound therapy[J]. Expert Rev Med Devices, 2014, 11(4): 395-402.
|
3 |
Kaye AE, Kaye AJ, Pahk B, et al. Sternal wound reconstruction: management in different cardiac populations[J]. Ann Plast Surg, 2010, 64(5): 658-666.
|
4 |
Hamman BL, Stout LY, Theologes TT, et al. Relation between topical application of platelet-rich plasma and vancomycin and severe deep sternal wound infections after a first median sternotomy[J]. Am J Cardiol, 2014, 113(8): 1415-1419.
|
5 |
孙斌,冯子阳,徐芳芳,等. 富血小板血浆预防胸骨感染效果的Meta分析[J]. 中国输血杂志,2015, 28(3): 295-298.
|
6 |
Serraino GF, Dominijanni A, Jiritano F, et al. Platelet-rich plasma inside the sternotomy wound reduces the incidence of sternal wound infections[J]. Int Wound J, 2015, 12(3): 260-264.
|
7 |
Dörge H, Sellin C, Bury MC, et al. Incidence of deep sternal wound infection is not reduced with autologous platelet rich plasma in high-risk cardiac surgery patients[J]. Thorac Cardiovasc Surg, 2013, 61(3): 180-184.
|
8 |
Lusini M, Di Martino A, Spadaccio C, et al. Resynthesis of sternal dehiscence with autologous bone graft and autologous platelet gel[J]. J Wound Care, 2012, 21(2): 74, 76-77.
|
9 |
Gallo I, Sáenz A, Artiñano E, et al. Autologous platelet-rich plasma: effect on sternal healing in the sheep model[J]. Interact Cardiovasc Thorac Surg, 2010, 11(3): 223-225.
|
10 |
Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting[J]. Am J Infect Control, 2008, 36(5): 309-332.
|
11 |
Matros E, Aranki SF, Bayer LR, et al. Reduction in incidence of deep sternal wound infections: random or real[J]. J Thorac Cardiovasc Surg, 2010, 139(3): 680-685.
|
12 |
Landes G, Harris PG, Sampalis JS, et al. Outcomes in the management of sternal dehiscence by plastic surgery: a ten-year review in one university center[J]. Ann Plast Surg, 2007, 59(6): 659-666.
|
13 |
周业平,田彭,杜伟力,等. 利奈唑胺治疗胸骨骨髓炎革兰阳性球菌感染的疗效分析[J/CD]. 中华损伤与修复杂志(电子版), 2011, 6(6): 966-969.
|
14 |
Kowalewski M, Pawliszak W, Zaborowska K, et al. Gentamicin-collagen sponge reduces the risk of sternal wound infections after heart surgery: Meta-analysis[J]. J Thorac Cardiovasc Surg, 2015, 149(6): 1631-1640.
|
15 |
周业平,田鹏,于东宁,等. 41例胸骨骨髓炎的外科综合治疗[J/CD].中华损伤与修复杂志(电子版), 2010, 5(3): 317-325.
|
16 |
Schulman NH, Subramanian V. Sternal wound reconstruction: 252 consecutive cases. The Lenox Hill experience[J]. Plast Reconstr Surg, 2004, 114(1): 44-48.
|
17 |
Spindler N, Lehmann S, Steinau HU, et al. Complication management after interventions on thoracic organs: deep sternal wound infections[J]. Chirurg, 2015, 86(3): 228-233.
|
18 |
Damiani G, Pinnarelli L, Sommella L, et al. Vacuum-assisted closure therapy for patients with infected sternal wounds: a meta-analysis of current evidence[J]. J Plast Reconstr Aesthet Surg, 2011, 64(9): 1119-1123.
|
19 |
唐冰,胡志成,朱家源,等. 开胸术后胸骨骨髓炎治疗的Meta分析[J/CD].中华损伤与修复杂志(电子版), 2012, 7(3): 273-278.
|
20 |
Mautner K, Malanga GA, Smith J, et al. A call for a standard classification system for future biologic research: the rationale for new PRP nomenclature[J]. PM R, 2015, 7(4 Suppl): S53-S59.
|
21 |
Almdahl SM, Veel T, Halvorsen P, et al. Randomized prospective trial of saphenous vein harvest site infection after wound closure with and without topical application of autologous platelet-rich plasma[J]. Eur J Cardiothorac Surg, 2011, 39(1): 44-48.
|
22 |
Yilmaz S, Aksoy E, Doganci S, et al. Autologous platelet-rich plasma in treatment of chronic venous leg ulcers: A prospective case series[J]. Vascular, 2015, 23(6): 580-585.
|
23 |
Knezevic NN, Candido KD, Desai R, et al. Is Platelet-Rich Plasma a Future Therapy in Pain Management[J]. Med Clin North Am, 2016, 100(1): 199-217.
|
24 |
Sakata J, Sasaki S, Handa K, et al. A retrospective, longitudinal study to evaluate healing lower extremity wounds in patients with diabetes mellitus and ischemia using standard protocols of care and platelet-rich plasma gel in a Japanese wound care program[J]. Ostomy Wound Manage, 2012, 58(4): 36-49.
|
25 |
Lawlor DK, Derose G, Harris KA, et al. The role of platelet-rich plasma in inguinal wound healing in vascular surgery patients[J]. Vasc Endovascular Surg, 2011, 45(3): 241-245.
|
26 |
Cobos R, Aizpuru F, Parraza N, et al. Effectiveness and efficiency of platelet rich plasma in the treatment of diabetic ulcers[J]. Curr Pharm Biotechnol, 2015, 16(7): 630-634.
|
27 |
Kakudo N, Morimoto N, Kushida S, et al. Platelet-rich plasma releasate promotes angiogenesis in vitro and in vivo[J]. Med Mol Morphol, 2014, 47(2): 83-89
|
28 |
Giannini S, Cielo A, Bonanome L, et al. Comparison between PRP, PRGF and PRF: lights and shadows in three similar but different protocols[J]. Eur Rev Med Pharmacol Sci, 2015, 19(6): 927-930.
|
29 |
Otvos L Jr, Ostorhazi E. Therapeutic utility of antibacterial peptides in wound healing[J]. Expert Rev Anti Infect Ther, 2015, 13(7): 871-881.
|
30 |
Bielecki TM, Gazdzik TS, Arendt J, et al. Antibacterial effect of autologous platelet gel enriched with growth factors and other active substances: an in vitro study[J]. J Bone Joint Surg Br, 2007, 89(3): 417-420.
|